Clinical Trials on Glucagon-Like Peptide-1 Receptor
Total 124 results
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Not yet recruitingGlucagon-Like Peptide-1 Receptor AgonistsChina
-
Hospital for Special Surgery, New YorkRecruitingGlucagon-like Peptide 1 | Gastric Ultrasound | Point of Care UltrasoundUnited States, Canada
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Philipps University Marburg Medical CenterCompletedDigestive Physiology | Gastrointestinal Motility | Gastrointestinal Hormones | Glucagon-like Peptide 1 | Exendin (9-39)Germany
-
Filip Krag KnopUniversity of CopenhagenCompletedTo Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 SecretionDenmark
-
Steno Diabetes Center CopenhagenUnknownEffect of Glucagon-like Peptide 2 on Gallbladder MotilityDenmark
-
University Hospital, Basel, SwitzerlandCompletedSmoking Cessation | Craving | Weight Change, Body | Glucagon-like Peptide-1Switzerland
-
Chinese PLA General HospitalCompletedCoronary Angiography | Glucagon-like Peptide-1
-
Chinese PLA General HospitalUnknownCoronary Angiography | Glucagon-Like Peptide 1China
-
Chinese PLA General HospitalCompletedBleeding | Complications | STEMI - ST Elevation Myocardial Infarction | Glucagon-like Peptide-1
-
University Hospital, Gentofte, CopenhagenDanish Heart FoundationCompletedType 2 Diabetes | Blood Flow | Human Physiology | Glucagon-like Peptide-1 | Blod PressureDenmark
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus | Diabetic Nephropathy | Diabetic Kidney Disease | Glucagon-Like Peptide 1Netherlands
-
Children's Hospital Medical Center, CincinnatiEnrolling by invitationDiabetes | Morbid Obesity | Delayed Gastric Emptying | Glucagon Like Peptide-1 (GLP-1 | Risk of AspirationUnited States
-
Medical University of South CarolinaCompletedDiabetes | Glucagon-like Peptide 1 | GLP-1 | Gastric Content AspirationUnited States
-
Uppsala UniversityCompletedQuality of Life | Neuroendocrine Tumors | Peptide Receptor Radionuclide Therapy
-
National Institute of Nursing Research (NINR)Not yet recruitingRyanodine Receptor 1-Related Myopathy | Ryanodine Receptor 1 Related DisordersUnited States
-
Erasmus Medical CenterRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide TherapyNetherlands
-
University Hospital of FerraraRecruitingNeuroendocrine Tumors | Peptide Receptor Radionuclide Therapy (PRRT)Italy
-
Calla IVF CenterCompletedImmunomodulatory Drugs | Killer-cell Immunoglobulin-like Receptors (KIRs) | KIR Alleles (KIR AA)Romania
-
University of CatanzaroUnknownAndrogen Receptor Abnormal | Insulin-Like Growth Factor I Deficiency | Insulin Receptor, Defect inItaly
-
National Institute of Arthritis and Musculoskeletal...National Institutes of Health Clinical Center (CC)Completed
-
Arno TherapeuticsUnknownProgesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone TherapyFrance
-
University of EdinburghNHS Lothian; DexCom, Inc.; Tandem Diabetes Care, Inc.; The Leona M. and Harry B...Active, not recruitingHypoglycemia | Type 1 Diabetes | Type 1 Diabetes Mellitus With Hypoglycemia | Hypoglycemia Unawareness | Glucagon Deficiency | Insulin HypoglycemiaUnited Kingdom
-
University of CopenhagenRigshospitalet, Denmark; Bispebjerg HospitalCompletedObesity | Type 1 Diabetes | Non-Alcoholic Fatty Liver Disease | Glucagon ResistanceDenmark
-
National and Kapodistrian University of AthensUnknownDiabetes Complications | Type 1 Diabetes | C-peptideGreece
-
Wright State UniversityRecruitingAging | UVB Phototherapy Burn | Insulin-like Growth Factor 1United States
-
Rhythm Pharmaceuticals, Inc.CompletedPro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene MutationsUnited States, Israel, Canada, Germany, Greece, Italy, Portugal
-
University GhentVrije Universiteit Brussel; Fund for Scientific Research, Flanders, BelgiumCompletedLife-limiting Cancer With Prognosis of Approximately 1 YearBelgium
-
University of ThessalyUnknown
-
FIDMAG Germanes HospitalàriesUniversity of BarcelonaCompletedMental Health Disorder | Mental Health Wellness 1 | Nurse's Role | Care Acceptor, Health | Relationship, Nurse PatientSpain
-
Merck Sharp & Dohme LLCCompletedAngina Pectoris | Coronary Heart Disease | Calcitonin Gene-related Peptide Receptor
-
Norwegian Institute of Public HealthThe Dam FoundationRecruitingQuality of Life | Wellbeing | Mental Health Wellness 1Norway
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
Fudan UniversityNot yet recruitingQuality of Life | Breast Cancer | Hormone Receptor-positive Breast CancerChina
-
Aga Khan UniversityCompleted
-
IpsenTerminatedrhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 DeficiencyInsulin-like Growth Factor-1 DeficiencyUnited States
-
Assiut UniversityRecruitingEvaluation of Serum Level of Insulin Like Growth Factor 1Egypt
-
IpsenTerminatedPrimary Insulin-like Growth Factor-1 DeficiencyUnited States
-
Near East University, TurkeyCompletedType 1 Diabetes MellitusTurkey
-
Gold Coast Hospital and Health ServiceUniversity of CanberraCompletedType 1 Diabetes MellitusAustralia
-
Taiwan AIDS Nurse SocietyGlaxoSmithKlineUnknown
-
Gilead SciencesCompleted
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
Shanghai Municipal Health BureauUnknownProteinuria | Angiotensin II Type 1 Receptor Blockers | Chronic Kidney Insufficiency | Angiotensin-Converting Enzyme InhibitorsChina
-
VA Puget Sound Health Care SystemNovartis Pharmaceuticals; University of WashingtonCompletedInflammation | Pulmonary Disease, Chronic Obstructive | Bronchitis, Chronic | Immunity, Innate | Toll-Like ReceptorsUnited States
-
Institut Cancerologie de l'OuestTerminatedMetastatic Breast Cancer | Positive Hormonal ReceptorsFrance
-
Pamukkale UniversityCompletedType 1 Diabetes MellitusTurkey
-
University of Ljubljana, Faculty of MedicineCompletedQuality of Life | Type 1 DiabetesSlovenia
-
Liverpool John Moores UniversityLiverpool University Hospitals NHS Foundation TrustCompletedType 1 DiabetesUnited Kingdom
-
Peking Union Medical College HospitalRecruitingEfficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GCChina